Kevin P. Kerns

Array ( [id] => 8421305 [patent_doc_number] => 08277792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Peptides for active anti-cytokine immunization' [patent_app_type] => utility [patent_app_number] => 13/362234 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6587 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13362234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664618 [patent_doc_number] => 08378079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Antibody to human zcyto-10 polypeptide' [patent_app_type] => utility [patent_app_number] => 13/361638 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15900 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13361638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8883511 [patent_doc_number] => 20130156695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'USE OF ZCYTOR17 LIGAND ANTAGONISTS FOR TREATING INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 13/359049 [patent_app_country] => US [patent_app_date] => 2012-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 80520 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13359049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9222392 [patent_doc_number] => 20140017167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'Anti-IL1RAP Antibodies and Their Use for Treating Human' [patent_app_type] => utility [patent_app_number] => 13/979475 [patent_app_country] => US [patent_app_date] => 2012-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14694 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8381461 [patent_doc_number] => 20120225080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'HUMAN ANTIBODIES THAT BIND THE P40 SUBUNIT OF HUMAN IL-12/IL-23 AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/350472 [patent_app_country] => US [patent_app_date] => 2012-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 46294 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13350472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289334 [patent_doc_number] => 20120177660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'BIOMARKERS AND THERAPEUTIC TARGETS FOR TYPE 1 DIABETES' [patent_app_type] => utility [patent_app_number] => 13/345067 [patent_app_country] => US [patent_app_date] => 2012-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16870 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13345067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307352 [patent_doc_number] => 20140046026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'SUPERAGONISTS AND ANTAGONISTS OF INTERLEUKIN-2' [patent_app_type] => utility [patent_app_number] => 13/997503 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17044 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13997503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476591 [patent_doc_number] => 20120275996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'IL-1 Binding Proteins' [patent_app_type] => utility [patent_app_number] => 13/331444 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41807 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13331444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8989261 [patent_doc_number] => 20130216542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'VARIABLE REGION SEQUENCES OF IL-31 MONOCLONAL ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/329392 [patent_app_country] => US [patent_app_date] => 2011-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 55294 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13329392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8208959 [patent_doc_number] => 20120128624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Recombinant Human Albumin-Granulocyte Macrophage Colony Stimulating Factor Fusion Protein With Long-Lasting Biological Effects' [patent_app_type] => utility [patent_app_number] => 13/327621 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 16302 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128624.pdf [firstpage_image] =>[orig_patent_app_number] => 13327621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11522724 [patent_doc_number] => 09606117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Bioassay for the early detection of autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 13/324963 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21626 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13324963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273092 [patent_doc_number] => 08637018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Humanized anti-IL-18 antibodies' [patent_app_type] => utility [patent_app_number] => 13/315358 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16550 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13315358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8457577 [patent_doc_number] => 08293241 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Anti-FGF19 antibodies and methods using same' [patent_app_type] => utility [patent_app_number] => 13/315220 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 47 [patent_no_of_words] => 56449 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13315220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8565990 [patent_doc_number] => 20120328561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'METHOD FOR TREATMENT OF INFLAMMATORY GASTROINTESTINAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/307782 [patent_app_country] => US [patent_app_date] => 2011-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10866 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13307782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209042 [patent_doc_number] => 20120128702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'NOVEL BIOMARKERS FOR A PREDICTION OF THE OUTCOME OF AN IMMUNOTHERAPY AGAINST CANCER' [patent_app_type] => utility [patent_app_number] => 13/302674 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12850 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128702.pdf [firstpage_image] =>[orig_patent_app_number] => 13302674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8554702 [patent_doc_number] => 08329171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Method for treating psoriatic arthritis by administering an anti-IL-12 antibody' [patent_app_type] => utility [patent_app_number] => 13/299874 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 31372 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13299874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239870 [patent_doc_number] => 20120148592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'NEUTRALIZING ANTI-CCL20 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/300352 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 38525 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13300352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8554701 [patent_doc_number] => 08329170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Method for treating psoriasis by administering an anti-IL-12 antibody' [patent_app_type] => utility [patent_app_number] => 13/299831 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 39785 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13299831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9139809 [patent_doc_number] => 08580264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Subcutaneously administered anti-IL-6 receptor antibody' [patent_app_type] => utility [patent_app_number] => 13/290366 [patent_app_country] => US [patent_app_date] => 2011-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 37 [patent_no_of_words] => 30354 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13290366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289332 [patent_doc_number] => 20120177658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'METHODS OF TREATMENT USING AN ANTI IL B50 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 13/287456 [patent_app_country] => US [patent_app_date] => 2011-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 25991 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13287456 [rel_patent_id] =>[rel_patent_doc_number] =>)